Detalhe da pesquisa
1.
Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000-2021.
Clin Infect Dis
; 2024 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38306502
2.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis
; 78(2): 248-258, 2024 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37738153
3.
In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals.
Antimicrob Agents Chemother
; 68(3): e0125823, 2024 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38289078
4.
International Epidemiology of Carbapenemase-Producing Escherichia coli.
Clin Infect Dis
; 77(4): 499-509, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37154071
5.
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S305-S313, 2023 10 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37843118
6.
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
Lancet Microbe
; 4(3): e159-e170, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36774938
7.
Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study.
Open Forum Infect Dis
; 9(11): ofac572, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36381622
8.
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Lancet Infect Dis
; 22(3): 401-412, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34767753